Join
Live feed
·
INSIDERFilingvia Quantisnow
Viking Therapeutics Inc. logo

Chief Financial Officer Zante Greg was granted 31,667 shares and sold $710,141 worth of shares (21,217 units at $33.47), increasing direct ownership by 5% to 212,204 units (SEC Form 4) (for tax liability)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VKTX (Viking Therapeutics Inc.) and more on Quantisnow.